Abstract
The decision on the best revascularization strategy for patients with multivessel disease has become a complex task as coronary angioplasty has improved its results. In the following review, we set out to evaluate the variables that, in our experience, define the benefit of one technique over the other, understanding that in this way the treating physician's decision will become simpler and more objective. On the other hand, and celebrating the healthy prominence given to patients, we believe that this evaluation allows solid arguments to help them in decision making. Key words: Percutaneous Coronary Angioplasty - Coronary Artery Bypass Graft - Multiple Vessels Disease How to cite this article Feder J, Gamarra AL, Conde D, Sigal A, Furmento J, Lamelas P, et al. Tools for Decision Making in Patients with Multivessel Disease. Rev Argent Cardiol 2023;91:349-56. http://dx.doi.org/10.7775/rac.v91.i5.20670

This publication has 36 references indexed in Scilit: